Skip to main content
. 2020 Mar 3;34(2):569–582. doi: 10.21873/invivo.11809

Table III. Metalloproteinase levels in each treatment group.

graphic file with name in_vivo-34-578-i0002.jpg

C: Control; APAP: acetaminophen administration; APAP+S: APAP and silymarin administration as pretreatment; APAP+LCC1: APAP and pretreatment with 1 mg/100 g bw LCC; APAP+LCC2: APAP and pretreatment with 2 mg/100 g bw LCC; Std: standard deviation; MMP-2: matrix matalloproteinase-2; MMP-9: matrix metalloproteinase-9.